Endocrine Abstracts

Continuous glucose monitoring (CGM) allows continuous real-time blood glucose monitoring and informs users of blood glucose trend data and alarms which warn users of high or low blood glucose readings. Current evidence suggests that CGM can reduce episodes of hypoglycaemia in conditions such as congenital hyperinsulinism and metabolic disorders. Hypoglycaemia secondary to these conditions is serious with almost 50% of children demonstrating neurological impairments as a result...

Objectives: The use of new diabetes technologies, such as insulin pumps, continuous glucose monitoring systems (CGMs) and hybrid closed-loop systems (HCL), is rapidly increasing among people with type 1 diabetes (T1DM). As these technologies are becoming an integral part of T1DM management, we expect an increase in the number of patients who present in the Accident and Emergency department (A&E) using them. The aim of this study was to assess and compare A...

Introduction: In many lower-middle income countries (LMICs), poverty, insufficient infrastructure and lack of universal health coverage affect type 1 diabetes (T1D) outcomes. Limited insulin and unavailability of blood glucose monitoring supplies contribute to poor glycaemic control and T1D complications that adversely affect mortality and morbidity. Laos is a LMIC in Southeast Asia (SEA) with a population of 7.3 million. Its GDP per capita is USD 2,534 of which only 2.5% repr...

Introduction: Globally, the main cause of mortality of type 1 diabetes (T1D) is lack insulin access. There is minimal data of health outcomes for T1D in low-middle-income countries (LMICs) in South-East Asia (SEA) where government funding of insulin and blood glucose monitoring kits either do not exist or is limited. Action4Diabetes (A4D) is a non-government organisation (NGO) initiated in 2016 and supports children and young people (CYP) with T1D in five countries -Laos, Mala...